Fasting insulin — the upstream marker that moves years before your glucose does
Paired condition: Prediabetes lab results
Quick answer
Fasting insulin measures how hard your pancreas is working to keep glucose normal. It's the single most under-ordered metabolic marker: insulin resistance drives insulin *up* for years while fasting glucose and HbA1c still read "normal." A normal glucose with a high-normal insulin is the classic early-dysfunction pattern — the number that's still reassuring while trouble builds underneath.
Reference ranges and interpretation
| Value / population | Classification | What it means |
|---|---|---|
| 2 – 5 µIU/mL | Optimal | Efficient glucose handling; low insulin resistance. |
| 5 – 10 µIU/mL | Normal but worth watching | Upper end often accompanies early insulin resistance. |
| 10 – 15 µIU/mL | Elevated | Insulin resistance likely underway even if glucose is normal. |
| > 15 µIU/mL | High | Marked insulin resistance; strong metabolic-risk signal. |
Assays and units vary (µIU/mL ≈ mIU/L). Most labs flag only values well above these; "in range" is not the same as "optimal." Interpret alongside fasting glucose to calculate HOMA-IR.
Why insulin moves first
HOMA-IR: turning two numbers into one
- 1.5 – 2.5 — early/borderline insulin resistance
- > 2.5 — insulin resistance likely
What to look at alongside fasting insulin
- HbA1c — the 3-month glucose average (lags insulin)
- Triglycerides + HDL — triglycerides rise and HDL falls with insulin resistance
- Triglyceride / HDL ratio — a widely used surrogate; < 2.0 is favorable
- ALT — fatty liver frequently accompanies insulin resistance
- Uric acid — often elevated in the same metabolic pattern
- Waist circumference / blood pressure — the non-lab pieces of metabolic syndrome
Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.
Start with my labs →Frequently asked questions
Why didn't my doctor order fasting insulin?
Fasting insulin isn't part of a standard metabolic panel and isn't required to diagnose diabetes, so it's often skipped. It's most valuable proactively — to catch insulin resistance while it's still reversible — which is exactly the window standard screening tends to miss.
Do I need to fast for this test?
Yes — a true fasting insulin requires 8–12 hours without food, ideally drawn at the same time as fasting glucose so the two can be combined into HOMA-IR. Any recent food will raise insulin and invalidate the interpretation.
Can fasting insulin be too low?
A low fasting insulin with normal glucose usually reflects good insulin sensitivity. Very low insulin with high glucose is a different picture (reduced insulin production) and should be evaluated by a clinician.
How fast can fasting insulin improve?
Faster than HbA1c. Because it reflects current metabolic demand rather than a 3-month average, fasting insulin and HOMA-IR can shift meaningfully within weeks of changes in diet, activity, sleep, and weight — which makes them useful short-term feedback markers.
References
All citations verified against PubMed / publisher of record (see note below for this page's verification date).
- 1.Matthews DR, Hosker JP, Rudenski AS, et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):412-419. — Original HOMA-IR model — source for the fasting glucose × insulin / 405 formula.PubMed →DOI →
- 2.DeFronzo RA, Tobin JD, Andres R. (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology. 237(3):E214-E223. — The euglycemic clamp — the reference standard HOMA-IR was validated against.PubMed →DOI →
- 3.Tabák AG, Jokela M, Akbaraly TN, et al. (2009). Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. The Lancet. 373(9682):2215-2221. — Shows insulin sensitivity/secretion changing years before glucose rises — the basis for treating insulin as an early marker.PubMed →DOI →
- 4.American Diabetes Association Professional Practice Committee. (2024). Standards of Care in Diabetes—2024. Diabetes Care. 47(Suppl 1):S1-S321. — Diagnostic thresholds for glucose/HbA1c that fasting insulin precedes.DOI →
Reference ranges vary by lab and assay. Optimal ranges reflect a proactive, longevity-oriented reading and are more conservative than standard lab flags. This page is educational and not a substitute for individualized medical advice.
By Steve Pinedo
Co-founder, Phi Longevity
Last updated: 2026-07-20
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →